Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up

<p>Abstract</p> <p>Clinical studies have confirmed that renal oncocytoma (RO) is a benign neoplasm with excellent prognosis. In diagnostically challenging cases of renal oncocytic epithelial neoplasms, fluorescent in-situ hybridization (FISH) is increasingly being used and its abil...

Full description

Bibliographic Details
Main Authors: Sherer Carol R, Acquafondata Marie B, Cieply Kathleen M, Bastacky Sheldon I, Dhir Rajiv, Dvorakova Marie, Mercuri Tracy L, Parwani Anil V
Format: Article
Language:English
Published: BMC 2010-05-01
Series:Diagnostic Pathology
Online Access:http://www.diagnosticpathology.org/content/5/1/32
_version_ 1811281748579844096
author Sherer Carol R
Acquafondata Marie B
Cieply Kathleen M
Bastacky Sheldon I
Dhir Rajiv
Dvorakova Marie
Mercuri Tracy L
Parwani Anil V
author_facet Sherer Carol R
Acquafondata Marie B
Cieply Kathleen M
Bastacky Sheldon I
Dhir Rajiv
Dvorakova Marie
Mercuri Tracy L
Parwani Anil V
author_sort Sherer Carol R
collection DOAJ
description <p>Abstract</p> <p>Clinical studies have confirmed that renal oncocytoma (RO) is a benign neoplasm with excellent prognosis. In diagnostically challenging cases of renal oncocytic epithelial neoplasms, fluorescent in-situ hybridization (FISH) is increasingly being used and its ability to distinguish RO from chromophobe renal cell carcinoma (ChRCC) has been documented. In this study, we evaluated the differential diagnostic contribution of FISH in cases of RO.</p> <p>Clinicopathologic data and glass slides from 73 patients with RO were reviewed; 20 cases of ChRCC were included for comparison. FISH analysis of formalin-fixed, paraffin-embedded sections was performed using centromeric probes for chromosomes 1, 2, 7 and 17. FISH analysis revealed ROs had frequent loss of signal for chromosome 1 (56%) and 17 (44%). Tumors with more than one loss were common (41%) and 10% cases showed loss of all chromosomes examined. A total of 18% cases did not show any abnormality.</p> <p>Our study shows that chromosomal abnormalities in both ROs and ChRCCs are common with frequent loss of chromosomes 1 and 17. No association was found between overall patient survival and the extent of chromosomal abnormalities. FISH results, even those showing significant chromosomal abnormalities, should not alter the primarily morphology-based diagnosis of RO.</p>
first_indexed 2024-04-13T01:39:11Z
format Article
id doaj.art-e74773b5f56b43b396b9d3053861d602
institution Directory Open Access Journal
issn 1746-1596
language English
last_indexed 2024-04-13T01:39:11Z
publishDate 2010-05-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj.art-e74773b5f56b43b396b9d3053861d6022022-12-22T03:08:15ZengBMCDiagnostic Pathology1746-15962010-05-01513210.1186/1746-1596-5-32Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-upSherer Carol RAcquafondata Marie BCieply Kathleen MBastacky Sheldon IDhir RajivDvorakova MarieMercuri Tracy LParwani Anil V<p>Abstract</p> <p>Clinical studies have confirmed that renal oncocytoma (RO) is a benign neoplasm with excellent prognosis. In diagnostically challenging cases of renal oncocytic epithelial neoplasms, fluorescent in-situ hybridization (FISH) is increasingly being used and its ability to distinguish RO from chromophobe renal cell carcinoma (ChRCC) has been documented. In this study, we evaluated the differential diagnostic contribution of FISH in cases of RO.</p> <p>Clinicopathologic data and glass slides from 73 patients with RO were reviewed; 20 cases of ChRCC were included for comparison. FISH analysis of formalin-fixed, paraffin-embedded sections was performed using centromeric probes for chromosomes 1, 2, 7 and 17. FISH analysis revealed ROs had frequent loss of signal for chromosome 1 (56%) and 17 (44%). Tumors with more than one loss were common (41%) and 10% cases showed loss of all chromosomes examined. A total of 18% cases did not show any abnormality.</p> <p>Our study shows that chromosomal abnormalities in both ROs and ChRCCs are common with frequent loss of chromosomes 1 and 17. No association was found between overall patient survival and the extent of chromosomal abnormalities. FISH results, even those showing significant chromosomal abnormalities, should not alter the primarily morphology-based diagnosis of RO.</p>http://www.diagnosticpathology.org/content/5/1/32
spellingShingle Sherer Carol R
Acquafondata Marie B
Cieply Kathleen M
Bastacky Sheldon I
Dhir Rajiv
Dvorakova Marie
Mercuri Tracy L
Parwani Anil V
Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
Diagnostic Pathology
title Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
title_full Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
title_fullStr Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
title_full_unstemmed Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
title_short Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
title_sort renal oncocytoma a comparative clinicopathologic study and fluorescent in situ hybridization analysis of 73 cases with long term follow up
url http://www.diagnosticpathology.org/content/5/1/32
work_keys_str_mv AT sherercarolr renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT acquafondatamarieb renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT cieplykathleenm renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT bastackysheldoni renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT dhirrajiv renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT dvorakovamarie renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT mercuritracyl renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup
AT parwanianilv renaloncocytomaacomparativeclinicopathologicstudyandfluorescentinsituhybridizationanalysisof73caseswithlongtermfollowup